2. IP for Scientists Universities Allied for Essential Medicines (UAEM) UC Berkeley

3. Agenda Patent law fundamentals Patenting @ Berkeley Office of Intellectual Property & Industry Research Alliances (IPIRA) University patenting and global health Who we are – UAEM

4. What is Intellectual Property? Intellectual Property (IP): person’s right to have control over the things s/he creates. Examples of types of IP PatentCopyrightTrademark

5. The Balance of IP Law IP is an attempt to balance between providing financial incentive for innovation and allowing for access to technologies Access Allow the public to use and benefit from the invention Ownership Promote research and protect investments Create competition

6. Patent Law – Give and Take What you give A written description of your invention Enablement: disclose how to make and use your invention Best mode: disclose the best mode of patenting your invention What you get An exclusive right to exclude others from making, selling, or using your invention for a limited period of time The power to assign or license your rights to someone else

7. What do universities do with patents? Licensing: letting a third party use the patented technology under certain conditions –Exclusive license –Non-exclusive license Licensor Licensee ResearchDecision to PatentLicense to Industry

8. Patenting @ Berkeley Office of Intellectual Property & Industry Research Alliances (IPIRA) Assistant Vice Chancellor Carol Mimura, Ph.D. [Picture of building]

9. Office of Intellectual Property & Industry Research Alliances (IPIRA) Office of Technology Licensing (OTL) Industry Alliances Office (IAO) One stop shop for industry-university relations, including sponsored research and intellectual property. (Assistant Vice Chancellor Carol Mimura )

10. Contact IPIRA for… Disclose an invention Material transfer Sponsored research agreement http://otl.berkeley.edu

11. University Licensing & Global Health: Why Should We Care? Gaps in Drug Development Pipeline –Lack of research –Lack of production Poor access –High, unaffordable prices –Lack of adaptive formulations for drugs Why? Business  profit-based incentives Result: Lack of access to life-saving drugs

12. What can universities do? Universities are major players in the drug development field – 40-50% of pharmaceutical industry’s new products rely on academic research.

13. What can Berkeley do? Berkeley - a history of public service –"The distinctive mission of the University is to serve society as a center of higher learning, providing long- term societal benefits through transmitting advanced knowledge, discovering new knowledge, and functioning as an active working repository of organized knowledge.” Socially responsible licensing

14. Socially Responsible Licensing Maximize the social benefit of discoveries made at Berkeley through equitable licensing Example policies –Royalty-free license terms for products sold in developing world –Requirement that licensees provide low-cost therapies for free or for minimal profit in developing world –Private-public partnerships (Peg Skorpinski photo)

15. Universities Allied for Essential Medicines International student organization Two-fold Mission –Ensuring access to life-saving medicines –Promoting research on neglected diseases www.essentialmedicine.org http://uaem.berkeley.edu